# A Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients with Renal Insufficiency and Healthy Subjects

> **NCT05208814** · PHASE1 · COMPLETED · sponsor: **Vigonvita Life Sciences** · enrollment: 16 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension
- Erectile Dysfunction

## Interventions

- **DRUG:** TPN171H single dose

## Key facts

- **NCT ID:** NCT05208814
- **Lead sponsor:** Vigonvita Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-31
- **Primary completion:** 2022-10-25
- **Final completion:** 2022-10-25
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2024-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05208814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05208814, "A Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients with Renal Insufficiency and Healthy Subjects". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05208814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*